Other Sites
- tummy tuck cost
- tummy tuck surgery
- breast enhancement
- saline breast implants
- Affordable medical tourism
- Boob job cost
- lower blepharoplasty
- What is medical tourism
- medical tourism companies
- breast augmentation surgery
- Calf implants
- Breast lift and augmentation
- abdominoplasty surgery cost
- breast enlargement surgery
- How much do breast implants cost
- body contouring surgery
- breast implant cost
- celebrity plastic surgery
- how much are breast implants
- The Truth about Silicone Breast Implants
-
Category Archives: Stem Cell Advances
Despite Significant Advances in the Treatment of Chronic Myeloid Leukemia (CML) Over the Last Decade, Hematologist …
BioTrends Research Group, LLC has released findings from the TreatmentTrends® CML report, in which 100 U.S. based hematologist-oncologists were surveyed about their current and expected treatment patterns for CML Continue reading
Posted in Stem Cell Advances
Tagged accelerated, blast-stage, condition--, current-and, reduced-overall, study-finds, treatment, treatmenttrends, trends-research, were-surveyed, which-100, with-chronic
Comments Off
Vaccine Innovators Convene to Discuss New Technologies
New technologies to produce vaccines more safely, quickly and economically than traditional approaches are featured at the New Cells, New Vaccines VI: Target to Market international scientific conference, currently underway through March 28 in Wilmington, Delaware, at the Hotel du Pont. Continue reading
Posted in Stem Cell Advances
Tagged cells, currently-underway, delaware, featured-at-the, march, market, more-safely, pont-, quickly-and, vaccines
Comments Off
Seattle Genetics Announces Pivotal ADCETRIS™ (Brentuximab Vedotin) Hodgkin Lymphoma Study Published in Journal of …
BOTHELL, Wash.–(BUSINESS WIRE)– Seattle Genetics, Inc. (Nasdaq:SGEN – News) today announced that the Journal of Clinical Oncology (JCO) published results of the companys pivotal clinical trial of ADCETRIS (brentuximab vedotin) in Hodgkin lymphoma (HL) patients with relapsed or refractory disease following an autologous stem cell transplant (ASCT). Continue reading
Posted in Stem Cell Advances
Tagged a-single-agent, accelerated, autologous-stem, journal, pivotal, professor, study, texas
Comments Off
Stem cell therapy possibly helpful in heart failure patients
Public release date: 24-Mar-2012 [ | E-mail | Share ] Contact: Beth Casteel bcasteel@acc.org 240-328-4549 American College of Cardiology CHICAGO — A new study found that using a patient’s own bone marrow cells may help repair damaged areas of the heart caused by heart failure, according to research presented today at the American College of Cardiology’s 61st Annual Scientific Session. Continue reading
Posted in Stem Cell Advances
Tagged a-catheter-into, cardiology, heart, improvement, into-the-heart, medicine-at-the, mononuclear, national, repair-damaged, study, texas, the-heart, with-the-number
Comments Off
Stem Cell Study Aids Quest for ALS Therapies
An article published in the journal Proceedings of the National Academy of Sciences reports a breakthrough using cutting-edge stem cell research, which could speed up the discovery of new treatments for amyotrophic lateral sclerosis (ALS) also known as motor neuron disease (MND) outside the United States.Washington, D.C. … Continue reading
Posted in Stem Cell Advances
Tagged als, discovery, for-amyotrophic, motor-neuron-, outside-the-united, proceedings, sciences, stem-cell, the-discovery, the-journal, united, united-states
Comments Off
Pair will receive $250G for outstanding research
A former student and teacher duo at the Massachusetts Institute of Technology will receive $250,000 from the March… Continue reading
Posted in Stem Cell Advances
Tagged and-teacher-, former-student, from-the-march, march, massachusetts, technology, will-receive
Comments Off
BioTimes Subsidiary OncoCyte Corporation Provides an Update on the Development of the Novel Pan-Cancer Diagnostic …
BioTime, Inc. (NYSE Amex: BTX) and BioTimes subsidiary OncoCyte Corporation today provided a progress report on the development of PanC-DxTM, a novel diagnostic device developed at Biotime and OncoCyte to detect the presence of various human cancers, including cancers of the breast, lung, bladder, uterus, stomach, and colon, during routine check-ups. By facilitating early non-invasive cancer detection, PanC-DxTM could lead to more successful therapeutic outcomes while reducing the costs of cancer monitoring and globally increasing the availability of affordable cancer screening. Continue reading
Posted in Stem Cell Advances
Tagged a-routine-blood, availability, california, corporation, european, plans--, presence-, south-korea, supreme
Comments Off
BioTime’s Subsidiary OncoCyte Corporation Provides an Update on the Development of the Novel Pan-Cancer Diagnostic …
ALAMEDA, Calif.–(BUSINESS WIRE)– BioTime, Inc. (NYSE Amex: BTX) and BioTimes subsidiary OncoCyte Corporation today provided a progress report on the development of PanC-DxTM, a novel diagnostic device developed at BioTime and OncoCyte to detect the presence of various human cancers, including cancers of the breast, lung, bladder, uterus, stomach, and colon, during routine check-ups. By facilitating early non-invasive cancer detection, PanC-DxTM could lead to more successful therapeutic outcomes while reducing the costs of cancer monitoring and globally increasing the availability of affordable cancer screening. Continue reading
Posted in Stem Cell Advances
Tagged availability, decision, diagnostic, european, plans--, presence-, south-korea, supreme, unique
Comments Off
Advances in regenerative medicine spark skin cell banking startup
Weve heard of people freezing their eggs, blood and stem cells for use later on, but a health service startup is now enabling patients to freeze their own skin cells for potential future use in diagnostics, therapeutics and regenerative medicine techniques. Next Healthcare Inc.s goal is to enable personalized healthcare by providing skin and stem cell banking directly to patients through their medical professional Continue reading
Posted in Stem Cell Advances
Tagged a-small-punch, allow-people, approaches-may, conditions-with, diseases, freeze-their, health-service, healthcare, now-enabling, patients-submit, people-freezing, providing-skin, their-medical
Comments Off
Third Aesthetic Plastic Surgery / Anti Aging Medicine: The Next Generation Symposium Brings Industry Leading Courses …
New York, March 21, 2012 /PRNewswire/ –The third Aesthetic Plastic Surgery / Anti Aging Medicine: The Next Generation Symposium will be held on July 20-22, 2012 at the Conrad New York, a new luxury complex overlooking the Hudson River in lower Manhattan. This interactive, multidisciplinary conference brings together world-class faculty from around the globe who will share ground-breaking research and practical advancements in aesthetic surgery, cosmetic medicine and anti-aging therapy. The Next Generation Symposium combines the best of continuing medical education, state-of-the-art information that is presented in a manner that encourages forward thinking among the core specialties of Plastic Surgery, Facial Plastic Surgery, Dermatology and Oculoplastic Surgery Continue reading
Posted in Stem Cell Advances
Tagged a-new-luxury, aging-medicine, conrad, course-chairman, expert-insights, facial-plastic, forward-looking, generation, hudson, hudson-river, interactive, medicine, plastic-surgery, presentations, what-the-future
Comments Off